Company Analysis

Aytu BioPharma, Inc. (AYTU)

Nasdaq: AYTU · Pharmaceutical Preparations · Denver, CO · filing with the SEC since 2007
Grade4.2
◀ Past 3.5● Present 5.3▶ Future 3.5
1 est.

Who runs Aytu BioPharma, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Disbrow Joshua R.
Chief Executive Officer. First filing Apr 2015, latest Jul 30, 2026, 10 filings in all.
Officers reporting now
4
of 8 people with a filing in the last fifteen months
Directors reporting now
4
22 people on the record since 2015
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Disbrow Joshua R.Chief Executive OfficerApr 2015Jul 30, 2026none
Selhorn Ryan JChief Financial OfficerNov 2024Jul 30, 2026none
Disbrow JarrettChief Business OfficerApr 2015Jul 30, 2026none
Pyszczymuka GregChief Commercial OfficerNov 2022Jul 30, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Dockery CarldirectorApr 2016Jul 30, 2026none
Donofrio John Jr.directorJul 2016Jul 30, 2026none
Jain AbhinavdirectorJun 2023Jul 30, 2026none
Liu Vivian HdirectorJul 2022Jul 30, 2026none
Earlier names on the record18, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton AYTU · research, not advice